Download
https://www.ndtvprofit.com/business/biocon-aims-to-list-biocon-biologics-in-india-in-next-2-3-years-annual-report?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
It is important for Biocon to unlock value of its biosimilars business, CEO Siddharth Mittal says in the annual report for FY20.
Share